Adenoid cystic carcinoma (ACC) is a rare and aggressive form of cancer that typically arises in the salivary glands, but can also occur in other areas such as the breast, trachea, or lungs. Despite its rarity, ACC poses significant challenges due to its slow growth and tendency to spread to distant organs, particularly the lungs. Research efforts in cancer biology and treatment strategies are intensifying to combat this disease. Scientists are investigating the genetic mutations and molecular pathways underlying ACC to identify potential targets for therapy. Immunotherapy, targeted therapies, and combination treatments are being explored in clinical trials to improve outcomes for patients with ACC. Moreover, advances in precision medicine hold promise for tailoring treatments to the individual characteristics of each patient's tumor, offering new hope in the fight against this challenging cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States